头颈肿瘤的术后放疗-胡超苏PPT课件.pptVIP

* * * * RTOG 9501addresses a particularly important question, relevant to a large group of patients, as estimates from patterns of care studies suggest that approximately one third of all head and neck cancer patients receive surgery and radiation as their principal treatment. There are also potentially significant implications for medical oncology practice, since these are patients in whom the medical oncologist has not historically not been involved in treatment. The study logically builds on prior work within the RTOG regarding both the efficacy of the concurrent cisplatin-radiation regimen